United Therapeutics

Beta Technologies designs and develops electric aircraft and related systems, including propulsion, energy storage, and flight control technologies, with a focus on clean aviation. It builds integrated solutions to enable scalable electric flight, including charging infrastructure and pilot training tools for cargo, medical, passenger, and defense applications, and supports a self-sufficient eVTOL ecosystem that aims to improve access to vertical mobility for logistics and healthcare transport.

SteadyMed Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative therapeutic product candidates. Based in San Ramon, California, with a research and development center in Rehovot, Israel, the company offers a unique delivery platform known as PatchPump, which is a customizable, pre-filled, and pre-programmed disposable device designed for large volume and viscous formulations. Among its key products is Trevyent, a single-use PatchPump pre-filled with treprostinil for the treatment of pulmonary arterial hypertension. SteadyMed also develops SMT-201 for the subcutaneous delivery of Ketorolac, a non-steroidal anti-inflammatory drug, and SMT-301 to deliver bupivacaine directly into surgical wound areas for localized pain relief. The company's innovative approach aims to enhance the delivery of injectable therapeutic drugs, addressing various medical needs such as pain management and chronic conditions.

Celularity is a clinical-stage biotechnology company focused on advancing cellular medicine through the development of off-the-shelf placental-derived allogeneic cell therapies. Its product pipeline includes unmodified and genetically modified natural killer (NK) cells, CAR-engineered T cells, and mesenchymal-like adherent stromal cells. The company targets various health conditions, including cancer, immunologic disorders, infectious diseases, and degenerative illnesses. Celularity leverages the unique biology of the placenta, aiming to create effective and accessible therapies to address significant unmet medical needs. In addition to its cell therapy initiatives, Celularity operates a bio-banking segment, which contributes substantially to its revenue.

The University of Alabama at Birmingham (UAB), established in 1969, is a distinguished institution located in Birmingham, Alabama. It offers a diverse range of over 130 undergraduate and graduate programs, including degrees in the arts, sciences, business, education, engineering, and public health. UAB is particularly renowned for its medical school, which encompasses one of the largest university medical centers in the United States. The university has produced numerous scholars and award recipients, such as Fulbright, Rhodes, and Truman scholars, reflecting the high caliber of its education. Student life at UAB is dynamic, featuring more than 150 student organizations, an active Greek community, and a top-ranking recreation and fitness center, alongside year-round intramural sports. Most students reside in on-campus housing, and UAB provides financial aid and departmental fellowships to support those in need of tuition assistance. Through its commitment to education, research, and community service, UAB addresses both local and global challenges while fostering a culture of discovery and innovation.

Revivicor is a regenerative medicine company specializing in using advanced animal biotechnology platforms to develop high-quality, abundant, and human-compatible tissues for treating human degenerative diseases. Its primary focus is on xenotransplantation, aiming to overcome the critical shortage of human organs through gene-edited pig organs.

Transoma Medicalis a provider of implantable wireless diagnostic systems for patients with chronic cardiovascular disease and for biomedical research. The company’s products include small wireless sensors that transmit information from inside the body to a receiver via radio-frequency waves, as well as unique software to condense the data these devices provide into meaningful information.

Medicomp specializes in the development and manufacturing of advanced ambulatory heart-monitoring systems, catering to the cardiac telemedicine and home sleep testing sectors. The company employs innovative diagnostic technologies and Diogenes algorithms to deliver comprehensive beat-to-beat analyses of the P-wave, as well as assessments of heart rate, rhythm, and QRS morphology. In addition to its monitoring systems, Medicomp provides patient reports, remote monitoring capabilities, and integration with electronic medical records, ensuring a seamless experience for healthcare providers and patients alike.

Cooke Pharma is a privately held company and is the exclusive maker of the HeartBar line of arginine-enriched products.

SynQuest, Inc. is a company that manufactured treprostinil, the bulk active ingredient in Remodulin.